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Ethnopharmacological relevance: The species Lippia gracilis Schauer, known in Brazil as “Alecrim-da-
chapada”, is popularly used in folk medicine to treat cough, bronchitis, nasal congestion, and headache.
Materials and methods: Lippia gracilis essential oil (EO; 10, 30, and 100mg/kg, p.o.) and the reference drugs
morphine (5mg/kg, p.o.) and acetylsalicylic acid (ASA; 200mg/kg, p.o.) were evaluated using models
for analgesia (acetic acid-induced contortion, formalin-induced licking, and hot plate) or inﬂammation
(formalin-induced licking response and subcutaneous air pouch model). To elucidate the antinociceptive
mechanism of action, animals were pre-treated with naloxone (opioid receptor antagonist; 1mg/kg, i.p.),
atropine (cholinergic antagonist; 1mg/kg, i.p.) or l-nitro arginine methyl ester (l-NAME; 3mg/kg, i.p.)
30min prior to oral administration of EO.
Results: EO signiﬁcantly inhibited the number of writhings in acetic acid-induced contortions and the
time that the animal spent licking the formalin-injected paw (second phase). All doses of EO increased
the baseline and the area under the curve in the hot plate model. The administration of naloxone did not
reverse theantinociceptiveeffect of EO in theacetic acid-inducedcontortionand formalin-induced licking
models. l-NAME and atropine signiﬁcantly reversed the effect of EO in themodels of contortion, formalin,
andhotplate. EOalso inhibited the inﬂammatoryprocess inducedby subcutaneous carrageenan injection,
reducing cell migration, exudate volume, extravased protein, and inﬂammatory mediators (nitric oxide,
prostaglandin E2, TNF-, and IFN-) produced in the pouch.
Conclusions: Our results indicate that the essential oil from Lippia gracilis produces an antinociceptive
effect that could be potentially mediated by cholinergic receptors and the nitric oxide pathway. Our data
inﬂam
n.
 also suggest that the anti-
oxide and PGE2 productio
. Introduction
The genus Lippia (Verbenaceae) is composed of approximately
50 species widely distributed in America and Africa (Aguiar and
osta, 2005). The species Lippia gracilis Schauer, known in Brazil as
Alecrim-da-chapada”, is an herb commonly found in northeast-
rn regions of Brazil (Matos et al., 1996). This species produces an
ssential oil (EO) containing great amounts of carvacrol, o-cymene,
-terpinene, and -caryophyllene (Silva et al., 2008).
∗ Corresponding author at: Laboratório de Farmacologia da Inﬂamac¸ão e doÓxido
ítrico, Programa de Desenvolvimento de Fármacos, ICB, Universidade Federal do
io de Janeiro, Av. Carlos Chagas Filho, 373, prédio doCCS, Bloco J, sala 10, 21941-902
io de Janeiro, Brazil. Tel.: +55 21 25626442; fax: +55 21 25626442.
E-mail address: patfern@farmaco.ufrj.br (P.D. Fernandes).
378-8741 © 2011 Elsevier Ireland Ltd. 
oi:10.1016/j.jep.2011.03.032
Open access under the Elsevier OA license. matory activity caused by EO exposure occurs through inhibition of nitric
© 2011 Elsevier Ireland Ltd. 
Several communities in northeastern Brazil use Lippia gra-
cilis to treat cough, bronchitis, nasal congestion, and headache
(Albuquerque et al., 2008). The essential oil is known to possess
antimicrobial activity and is used externally to treat cutaneous dis-
eases, burns, wounds, and ulcers (Pascual et al., 2001). Recently,
Mendes et al., 2010 demonstrated the antinociceptive and anti-
inﬂammatory activities of Lippia gracilis essential oil derived from
a specimen cultivated at the Experimental Station “Campus Rural”
of the Federal University of Sergipe. This study, however, did not
explore the mechanisms underlying these effects, did not iden-
Open access under the Elsevier OA license.tify the inﬂammatory mediators involved in this process, and
did not attempt to elucidate the mechanisms responsible for
the observed antinociceptive activity. In addition to the other
studies of Lippia gracilis, this paper describes the inﬂammatory
mediators that demonstrate altered production and attempts to
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dentify the mechanism by which the observed antinociceptive
ctivity occurs. Additionally, the toxicity of the essential oil was
nvestigated.
. Materials and methods
.1. Plant material and phytochemical analysis
Lippia gracilis HBK was cultivated at the Research farm of
he Federal University of Sergipe, Department of Agronomical
ngineering, São Cristóvão, Brazil. Voucher specimen 08,214 was
eposited in the Federal University of SergipeHerbarium, Universi-
ade Federal de Sergipe, CCBS, Departamento de Biologia (Sergipe,
razil).
Prior to hydrodistillation, leaves were dried at 40 ◦C in a
orced air oven (Marconi MA 037) for 48h. Dry Lippia gracilis
as pulverised in a mill and submitted to hydrodistillation in a
levenger-typeapparatus consistingof a3000mldistillationbottle,
7ml graduated receiver, and a jacketed-coil condenser. A total of
00g of dried plant material and 1500ml of H2O was used, and dis-
illationwas carried out for 4h. Condensation of the steam followed
y accumulation of the essential oil/water system in the gradu-
ted receiver resulted in separation of the essential oil from the
ater, allowing manual collection of the organic phase. Traces of
aterwere removed by freezing the sample below0 ◦C followed by
ransferring unfrozen essential oil to a new vial to yield a yellowish
olatile oil (2.8%, w/v).
.2. Analytical conditions
Theessential oil (EO)obtainedbyhydrodistillationwasanalysed
y GC/MS according to Silva et al. (2008). A DB-5MS fused silica
olumn (30m×0.25mm; ﬁlm thickness of 0.25m) was used. The
C/MS was run under the following conditions: helium as a carrier
as at 1ml/min, injector split at 250 ◦C (split ratio 1/20), detector
t 280 ◦C, and a speciﬁed column temperature program (80 ◦C for
.5min, 4 ◦C increases per min to 180 ◦C, 10 ◦C increases per min
o 300 ◦C, and an ending 10-min isothermal at 300 ◦C). The mass
pectra were taken at 70eV with a scanning speed of 0.85 scan/s
rom 40 to 550Da. Peak identiﬁcations were assigned on the basis
f a comparison of their retention indices relative to an n-alkane
omologous series obtained by co-injecting the oil sample with a
inear hydrocarbon mixture.
.3. Animals
All experiments were performed with male Balb/C mice
20–25g) obtained from our own animal facility. Animals were
aintained in a temperature-controlled room (22±2 ◦C) for 12h
ight/dark cycles with free access to food and water. 12h prior to
ach experiment, the animals were limited to a water-only diet
n order to avoid food interference with substance absorption. Ani-
al care and research protocols (ICBDFBC-015)were in accordance
ith the principles and guidelines adopted by the Brazilian Col-
ege of Animal Experimentation (COBEA) and were approved by
he Ethical Committee for Animal Research (Biomedical Science
nstitute/UFRJ).
.4. Drugs and essential oil administration
l-Nitro arginine methyl ester (l-NAME), atropine, carrageenan,
ndacetylsalicylic acid (ASA)werepurchased fromSigma (St. Louis,
O, USA). Acetic acid andmorphine hydrochloridewere purchased
romMerck Inc. (Brazil), andnaloxonewaspurchased fromCristália
São Paulo, Brazil). All drugs were dissolved in phosphate buffer
aline (PBS) just before use. The EO was dissolved in sterile corn oilrmacology 135 (2011) 406–413 407
andadministeredbyoral gavage at doses of 1, 10, 30, and100mg/kg
inaﬁnalvolumeof0.1ml.Morphine (5mg/kg)andASA(200mg/kg)
were used as reference drugs and were administered via oral gav-
age. The negative control group was composed of mice given the
vehicle (corn oil); signiﬁcant effects due to the corn oil per se were
not observed throughout the study.
2.5. Acute toxicity
Acute toxicity parameters were determined as described by
Lorke (1983). Oral doses of EO (2, 3, and 4g/kg) were adminis-
tered to groups of tenmice (ﬁvemales and ﬁve females). Behaviour
parameters, including convulsion, hyperactivity, sedation, groom-
ing, loss of righting reﬂex, increased or decreased respiration,
and food and water intake were observed over a period of 5
days. After this period, animals were sacriﬁced by cervical dis-
location, stomachs were removed, an incision along the greater
curvature was made, and the number of ulcers (single or multiple
erosion, ulcer or perforation) and instances of hyperaemia were
counted.
2.6. Acetic acid-induced abdominal writhing
Mice were used according to Matheus et al. (2005). Brieﬂy, the
total number ofwrithings following intraperitoneal administration
of a 2% (v/v) acetic acid solution (AA) was recorded over a period
of 20min, starting 5min after AA injection. Mice were pre-treated
with vehicle, ASA, or EO 60min prior to AA administration. The
doses and the routes of administration are provided in Section 2.4.
2.7. Formalin test
The formalin test was conducted in a manner similar to that
described by Hunskaar and Hole (1987), with some modiﬁcations
used by Gomes et al. (2007). Animals received an injection of 20l
of formalin (2.5%, v/v) in the dorsal surface of the left hind paw.
Immediately following the injection, the time that the animal spent
licking the injected paw was recorded. The nociceptive response
consists of two phases. The ﬁrst phase occurs 5min after formalin
injection (neurogenic pain response), and the second phase occurs
15–30min after formalin injection (inﬂammatory pain response).
The animals were pre-treated with oral doses of vehicle, ASA, or EO
60min before formalin administration. The doses and the routes of
administration are provided in Section 2.4.
2.8. Hot plate test
Mice were subjected to the hot plate test following the method
described by Sahley and Berntson (1979) and adapted by Matheus
et al. (2005). Animals were placed on a hot plate (Insight equip-
ments, Brazil) set at 55±1 ◦C. Reaction time was recorded when
the animals licked their forepaws or hindpaws and jumped at sev-
eral intervals of 30min following oral administration of vehicle,
morphine, or EO. The doses and the routes of administration are
provided in Section 2.4. Baseline levels were deﬁned as the mean
of the reaction times obtained at 60 and 30min prior to adminis-
tration of vehicle, EO, or morphine. Increases in baseline levels (%)
were then calculated [((reaction time×100)/baseline)−100].
2.9. Evaluation of the mechanism of antinociceptive action of
Lippia gracilisTo assess the possible participation of the opioid, cholinergic,
and nitric oxide systems in the antinociceptive effect of the essen-
tial oil from Lippia gracilis, mice were pre-treated with naloxone
(1mg/kg, i.p.), atropine (1mg/kg, i.p.) or l-nitro arginine methyl
4 nopharmacology 135 (2011) 406–413
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Table 1
Essential oil composition from the leaves of Lippia gracilis characterized by GC/MS.
RI Compound Lippia gracilis (%)
1023 o-Cymene 9.42
1057 -Terpinene 9.16
1228 2-Isopropyl-5-methylanisole 5.85
1288 Thymol 3.83
1297 Carvacrol 44.4308 C.C. Guilhon et al. / Journal of Eth
ster (l-NAME; 3mg/kg, i.p.) 30min before EO (30mg/kg, p.o.).
he doses of the antagonists were selected based on previous
esults from our laboratory (Pinheiro et al., 2010). The nocicep-
ive response was evaluated by AA-induced contortions, formalin,
nd hot plate methods. Using the hot plate method, antinocicep-
ion was quantiﬁed as either the increase from in baseline (%),
alculated by the formula (reaction time×100/baseline)−100, or
he area under the curve (AUC) deﬁning the interval from 30 to
80min following drug administration. A formula based on the
rapezoid rule was used to calculate the AUC [AUC=30× IB [(min
0) + (min 60) + · · ·+ (min 180)/2], where IB is the increase from
aseline (%)].
.10. Subcutaneous air pouch (SAP)
The SAP protocol used was similar to that described by
aymundo et al. (2011). Brieﬂy, air pouches were produced by sub-
utaneous injections of 10ml of sterile air into the intrascapular
egion of the mice. After 3 days, another 10ml of air was injected to
aintain the pouches. Three days after this last injection, animals
eceived an injection of 0.5ml of sterile carrageenan suspension
1%). Mice were pre-treated with oral doses of vehicle, dexam-
thasone (0.5mg/kg), or EO 1h before and 23h after carrageenan
njections in the SAP. Animals were sacriﬁced 24h after the car-
ageenan injection, and the cavity was washed with 2ml of sterile
BS. Exudates were collected and quantiﬁed. An aliquot of exu-
ates was diluted 1:20 in Türk liquid (0.5% crystal violet dissolved
n 30% acetic acid). The total number of cells was determined using
hemocytometer. The exudates were centrifuged at 170× g for
0minat 4 ◦C; the supernatantswere collected and storedat−20 ◦C
ntil further analysis.
.11. FN- , TNF-˛, PGE2, and protein meassurements
Supernatants from exudates collected in the SAP were used to
easure TNF-, IFN, NO, protein, and PGE2. TNF- and IFN were
uantiﬁed by enzyme-linked immunosorbent assay (ELISA), using
he protocol supplied by the manufacturer (Peprotech). PGE2 was
etermined by using EIA kits (Cayman Chemical Co., MI, USA),
ccording to the method of Pradelles et al. (1985). The protein con-
ent of each supernatant was determined using the BCA method
BCATM Protein Assay Kit, Pierce).
.12. Nitrate measurement
To evaluate NOproduction, nitrate (the stablemetabolite of NO)
oncentration in the supernatants was measured according to Xu
tal. (2000)with severalmodiﬁcations (Raymundoet al., 2011). The
bsorbancewasmeasured at 540nmusing amicroplate reader, and
he nitrate concentration was calculated using a standard curve of
odium nitrate.
.13. Statistical analysis
All experimental groups were composed of 6–10 mice. The
esults are presented as mean± S.D. The area under the curve
AUC) was calculated by Prism Software 5.0. Statistical signiﬁcance
etween groups was determined by analyses of variance (ANOVA)
ollowedbyBonferroni’s test.pvalues less than0.05 (*p<0.05)were
onsidered signiﬁcant.. Results
The essential oil of Lippia gracilis was obtained in 2.8% yield.
hirty-four compounds, representing 98.39% of the essential oil,
ave been identiﬁed (Silva et al., 2008). The retention indices and1422 -Caryophyllene 8.83
RI: relative retention index calculated against n-alkanes applying the Van den Dool
equation. %: compound percentage.
percentage compositions of the major compounds are given in
Table 1. The major components in Lippia gracilis essential oil were
identiﬁed as carvacrol (44.43%), o-cymene (9.42%), -terpinene
(9.16%), and -caryophyllene (8.83%).
Oral administration of the essential oil (EO) of Lippia gracilis at
500mg/kg dose did not induce any toxic effect. No behavioural
alteration, lesions, or gastric bleeding was observed. Additionally,
no signs of intoxication, including convulsion, death, or gastric
ulcer,wereobservedevenafter 5daysof a singledose. In anattempt
to calculate the lethal dose (LD50), groups of mice received the EO
in doses of 2, 3, and 4mg/kg. At the highest dose of EO, lethality
was not observed indicating that EO was nearly nontoxic in mice
up to this dose and that it was not possible to determine the LD50.
3.1. Antinociceptive effect of the EO from Lippia gracilis
The central and peripheral antinociceptive effects of the EO
derived from Lippia gracilis were evaluated using different pain
stimuli, such as heat (hot plate) and chemical agents (acetic acid
and formalin). To evaluate the peripheral antinociceptive effect,
groups ofmice that received oral doses of EO received i.p. injections
of acetic acid. The group of mice pre-treated with vehicle devel-
oped 46.0±7.4 writhings in an interval of 20min. When animals
were pre-treated with increasing doses of Lippia gracilis, a similar
degree of inhibitionwith all doses tested (10, 30, or 100mg/kg)was
observed (Fig. 1A). As the 1mg/kg dose did not inhibit writhings,
we decided to not test this dose further in the othermodel systems.
To conﬁrm the peripheral anti-hyperalgesic effect, we used the for-
malin model. With this model, we can access the antinociceptive
effect, andwe can also evaluate a possible anti-inﬂammatory effect.
As depicted in Fig. 1B, the doses tested (10, 30 or 100mg/kg) did not
reduce the time that the animal spent licking the formalin-injected
paw in the ﬁrst phase. All doses of EO did, however, signiﬁcantly
reduce the time of licking in the second phase after the formalin
injection.
When tested in the central antinociceptive model (hot plate
model), the pre-treatment of mice with EO (10–100mg/kg)
resulted in signiﬁcant anti-hyperalgesic activity with all doses
tested. At 30min after oral administration, all EO doses resulted
in signiﬁcantly increased activity, and the maximal effect was
observed for 10 and 30mg/kg doses. The maximal effect for the
100mg/kg dose was observed 60min after oral administration. For
all doses tested, antinociceptive effects returned to basal levels
90min after EO administration. Pre-treatment of mice with vehicle
did not induce any signiﬁcant antinociceptive effect (Fig. 2A). In an
attempt to better visualise these effects and compare them to those
obtained from the positive group (morphine), the values observed
for each curve were converted to AUC. Fig. 2B shows that the 10,
30, and 100mg/kg EO doses had an AUC signiﬁcantly different
from the vehicle-treated group. When comparing results obtained
with EO- and morphine-treated animals, it should be noted that
the highest dose of EO had a similar AUC to that obtained with
morphine.
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Fig. 1. Effects of Lippia gracilis essential oil on acetic acid-induced abdominal
writhing (A) and formalin-induced licking (B) in mice. Animals were pre-treated by
oral administration with different doses of Lippia gracilis essential oil (open bars),
acetylsalicylic acid (ASA; 200mg/kg, gray bars), or vehicle (black bars). The results
are presented as mean± S.D. (n=6–10) of writhings or time that the animal spent
licking the formalin-injected paw. Statistical signiﬁcance was calculated by ANOVA
followed by Bonferroni’s test. Asterisk (*) indicates p<0.05 when compared to the
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Fig. 2. Effects of Lippia gracilis essential oil in the hot platemodel. Animalswere pre-
treated by oral administration with different doses of Lippia gracilis. Control groups
were composed of vehicle or morphine (5mg/kg, p.o.). The results are presented as
mean± S.D. (n=6–10) of the increase in baseline levels (%, in A) or area under the
curve calculated by Prism Software 5.0 (B). Statistical signiﬁcance was calculated by
In this study, we characterise the inﬂammatory mediators byehicle-treated mice.
.2. Evaluation of the antinociceptive mechanism of action of
ippia gracilis
In order to evaluate a possible mechanism underlying the
ntinociceptive effect of Lippia gracilis, we assessed the involve-
ent of opioid, cholinergic, and nitric oxide (NO) systems in
he effects observed following EO exposure. 30min prior to EO
reatment, mice were systemically dosed with each inhibitor, and
he antinociceptive effects of Lippia gracilis were evaluated based
n acetic acid-induced writhings, formalin-induced licking, and
ot plate models. The opioid antagonist, naloxone (1mg/kg, i.p.),
id not reverse the anti-hyperalgesic effect of Lippia gracilis (at
0mg/kg) for either acetic acid-induced writhings or formalin-
nduced licking. The cholinergic antagonist, atropine (1mg/kg, i.p.),
ad signiﬁcantly reduced the antinociceptive activity of the EO in
oth models. Similarly, the nitric oxide synthase inhibitor, l-NAME
3mg/kg, i.p.), slightly reduced the anti-hyperalgesia induced by
ippia gracilis (Fig. 3A and B). All three antagonists were able
o inhibit the anti-hyperalgesic effect of Lippia gracilis in the
ot plate model. In this model, naloxone and l-NAME partially
eversed the effect, and atropine completely abolished the increase
n baseline levels (and AUC) induced by the EO (Fig. 4A and
).ANOVA followed by Bonferroni’s test. Asterisk (*) indicates p<0.05when comparing
Lippia gracilis- or morphine-treated mice to the vehicle-treated group. Absence of
error bars indicates that they are smaller than the symbol.
3.3. Anti-inﬂammatory activity of Lippia gracilis
The anti-inﬂammatory effect observed in the second phase of
formalin-induced licking led us to evaluate the effects of Lippia
gracilis essential oil in an additional model of inﬂammation, the
subcutaneous air pouch (SAP) model. This model allows us to both
evaluate cell migration and quantify the inﬂammatory mediators
produced in the system.
Injection of 1ml of carrageenan (1% in PBS) into SAP increased
exudate volume collected from the pouch. Carrageenan exposure
also resulted in a 31.7-fold increase in the number of leukocytes
that migrated to the cavity. Pre-treatment with EO (10, 30, or
100mg/kg) signiﬁcantly reduced the volumeof recovered exudates
and inhibited the number of leukocytes (Fig. 5).
This inﬂammatory response was also accompanied by an
increase in the levels of protein and the cytokines IFN- and TNF-.
Additionally, increased levels of nitric oxide (NO) and PGE2 were
observed. Pre-treatment of mice with Lippia gracilis signiﬁcantly
suppressed the carrageenan-induced protein leakage (259.8±33.7
in the vehicle-treated group vs. 192.2±23.8, 154.9±28.7, and
122.6±33.4 in the 10, 30, and 100mg/kg Lippia gracilis-treated
group, respectively), cytokines, NO, and PGE2 production in a dose-
dependent manner (Fig. 6).
4. Discussioninhibiting their production, identify the peripheral and central
antinociceptive effect, and attempt to identify the antinociceptive
mechanism of action for Lippia gracilis essential oil.
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Fig. 3. Effects of different antagonists on the antinociceptive activity of Lippia gra-
cilis essential oil in the acetic acid-induced contortions model (A) or in the second
phase of the formalin-induced licking (B) response. Animals were pre-treated with
naloxone (1mg/kg, i.p.), atropine (1mg/kg, i.p.), or l-NAME (3mg/kg, i.p.) 30min
prior to oral administration of Lippia gracilis essential oil (30mg/kg, p.o.). Results
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Fig. 4. Effects of different antagonists on the antinociceptive activity of Lippia gra-
cilis essential oil in the hot plate model. Animals were pre-treated with naloxone
(1mg/kg, i.p.), atropine (1mg/kg, i.p.) or l-NAME (3mg/kg, i.p.) 30min prior to oral
administration of Lippia gracilis essential oil (30mg/kg, p.o.). The results are pre-
sented as mean± S.D. (n=6–10) of the increase in baseline levels (A) or area under
the curve (B) calculated by Prism Software 5.0. Statistical signiﬁcance was calcu-
lated by ANOVA followed by Bonferroni’s test. Asterisk (*) indicates p<0.05 whenre presented as mean± S.D. (n=6–10) of total writhings or time that the animal
pent licking the formalin-injected paw. Asterisk (*) indicates p<0.05 when com-
aring Lippia gracilis-treatedmice to the vehicle-treated group; (#) indicatesp<0.05
hen comparing antagonists-treated mice with the Lippia gracilis-treated group.
The most common use of the Lippia species is for the treatment
f respiratory disorders (Pascual et al., 2001). While several species
f Lippia have been studied, little is known regarding Lippia gra-
ilis. Recently, Mendes et al. (2010) demonstrated antinociceptive
nd anti-inﬂammatory activities from a specimen of Lippia gra-
ilis cultivated in the Experimental Station “Campus Rural” of the
ederal University of Sergipe. In this paper, authors used acetic
cid-induced writhings to demonstrate an antinociceptive effect of
ippia gracilis. Paw edema and carrageenan induced cell migration
ere observed as indicators of inﬂammation.
Despite these ﬁndings, authors did not attempt to identify if the
rigin of the antinociceptive effect was central or peripheral, nor
id they attempt to identify the mechanism of action by which this
ffect occurred. They also did not characterise the inﬂammatory
rocess inhibited by Lippia gracilis. It is important to note that the
oses of Lippia gracilis tested in this study (50–200mg/kg) were
igher than the doses used in our study, which could explain the
ifferences in our results.
The ability to reduce acetic acid-induced writhings and
ormalin-induced licking responses are indicative of an anti-
nﬂammatory effect. The AA-induced writhings model has beencomparing Lippia gracilis- or morphine-treated mice to the vehicle-treated group;
(#) indicates p<0.05 when comparing antagonists-treated mice with the Lippia
gracilis-treated group.
used as a screening tool for the assessment of analgesic or anti-
inﬂammatory agents (Collier et al., 1968). These authors postulated
that acetic acid acts by inducing the release of mediators that can
stimulate the nociceptive neurons sensitive to non-steroidal anti-
inﬂammatory drugs and narcotics. The mediators (i.e., histamine,
serotonin, bradykinin and others) released into peritoneal ﬂuid
cause an increase in vascular permeability, reduce the threshold
of nociception and stimulate the nervous terminal of nociceptive
ﬁbres (Deraedt et al., 1980;Martinez et al., 1999; Ikeda et al., 2001).
The potential anti-inﬂammatory effect from Lippia graciliswas con-
ﬁrmed by the formalin-induced licking model. This model can also
be used to elucidate the mechanisms of pain and analgesia (Tjølsen
et al., 1992). Centrally acting drugs such as narcotics inhibit the
two phases of nociceptive response equally (Shibata et al., 1989),
but drugs with peripheral action, such as aspirin and dexametha-
sone, inhibit only the second phase (Hunskaar and Hole, 1987;
C.C. Guilhon et al. / Journal of Ethnopharmacology 135 (2011) 406–413 411
Fig. 5. Effect of Lippia gracilis essential oil using the subcutaneous air pouch (SAP)
model. Animals were pre-treated by oral administration with different doses of
Lippia gracilis 24h prior and 1h prior to injecting carrageenan (1%) into the SAP.
The results are presented as mean± S.D. (n=6–10) of total leukocytes (×106/ml)
or exudate volume (ml). Statistical signiﬁcance was calculated by ANOVA followed
b
t
v
R
o
m
m
b
a
o
w
t
p
b
r
c
c
o
m
r
t
f
o
r
w
a
1
f
n
r
r
c
p
e
a
i
Fig. 6. Effect of Lippia gracilis essential oil onnitric oxide (NO), PGE2, TNF-, and IFN-
 production in the subcutaneous air pouch (SAP) model. Animals were pre-treated
by oral administration with different doses of Lippia gracilis 24h and 1h prior to
injecting carrageenan (1%) into the SAP. The results are presented as mean± S.D.
(n=6–10) of NO (M), PGE2 (pg/ml), TNF- (ng/ml), and IFN- (ng/ml). Statisti-
known to be responsible for the anti-inﬂammatory effect. To testy Bonferroni’s test. Asterisk (*) indicates p<0.05 when comparing Lippia gracilis-
reated mice with the vehicle-treated group; (#) indicates p<0.05 when comparing
ehicle-treated mice to the PBS-treated group.
osland et al., 1990). Our results demonstrate that the essential
il can reduce the second phase of nociceptive response in the for-
alin model, indicating an anti-inﬂammatory effect. A potential
echanism underlying the anti-inﬂammatory response produced
y Lippia gracilis could be due to either the disruption of medi-
tor formation or by inhibition of receptor function. The results
bserved in the formalin model complement the data obtained
ith the acetic acid-induced writhing model following L. gracilis
reatment.
The central antinociceptive effect was evaluated using the hot
latemodel. In thismodel, the effects of EOwere rapidly detectable,
ut then began to decline 60min following treatment ultimately
eturning to baseline levels. Although EO could produce a signiﬁ-
ant central response, this effect appeared to be transient.
The hydrophilic/lipophilic relationship and the time that the
ompound remains in the central nervous system may explain this
bservation. It may be that the lipophilic characteristic of EO per-
its rapid penetration through blood–brain barrier, allowing it to
each the central nervous system.
The mechanism of action of Lippia gracilis was investigated
hrough the pre-treatment of animalswith several drugs that inter-
ere in different systems. Our results demonstrate the participation
f the nitric oxide (NO) pathway in the anti-hyperalgesic effect
esulting from EO treatment. These results are also in agreement
ith studies suggesting that NO is an important mediator in the
ntinociception activity of several drugs (Granados-Soto et al.,
997; Sachs et al., 2004; Brito et al., 2006). Additional studies have
ound that NO can either decrease or increase responsiveness of
ociceptors. This activity may depend on the baseline level of neu-
onal excitability (Levy and Strassman, 2004) and could explain the
esults showing that low doses of NO are associated with antinoci-
eption, as opposed to medium or high doses that are known to
roduce nociception (Prado et al., 2002). Thus, any attempt to
xplain our results may be complicated by the knowledge that the
mount of locally synthesised NO is model-dependent. This could
nﬂuence the effects observed under conditions of NO inhibition.cal signiﬁcance was calculated by ANOVA followed by Bonferroni’s test. Asterisk
(*) indicates p<0.05 when comparing Lippia gracilis-treated mice with the vehicle-
treated group; (#) indicates p<0.05 when comparing vehicle-treated mice with the
PBS-treated group.
Our results clearly indicate the involvement of cholinergic
receptors in this process, as atropine inhibited the antinociceptive
effect of Lippia gracilis. A major site of action for cholinomimet-
ics in analgesia is the spinal cord. Painful stimuli are known to
increase acetylcholine in the spinal cord. The activation of mus-
carinic receptors in the spinal cord results in the increased release
of inhibitory transmitters anddecreased releaseof excitatory trans-
mitters, and this activation, in part, mediates their antinociceptive
effects (Jones and Dunlop, 2007). The involvement of the opioid
system in the antinociceptive activity of Lippia gracilis was also
observed, as naloxone (opioid antagonist) treatment resulted in a
partial reversal of the anti-hyperalgesic effect.
Taken together, these results suggest that the constituents in the
essential oil may be acting through different pathways to produce
the observed antinociceptive activity. As such, it is likely that the
mechanismsunderlying this activity aremulti-fold andwill require
further investigation.
As the essential oil of Lippia gracilis exhibited an inhibitory effect
during the second phase of the formalin-induced licking response,
we decided to assess the inhibition of inﬂammatory mediatorsthis, we used the subcutaneous air pouch model.
In this model, the injection of carrageenan increased both
exudate volume and exudate protein concentration, indicating vas-
cular leakage of serum contents. Among diverse inﬂammatory
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ediators that can induce vascular permeability, it is well known
hat NO and PGE2 are factors involved in many inﬂammatory pro-
esses (Guslandi, 1998; Ritchlin et al., 2003) and in pain induction
nd perception (Hunskaar and Hole, 1987; Pang and Hoult, 1997).
GE2 increases in parallelwith tissue edema, a conditionwhich can
e suppressed by NSAIDs (inhibitors of COX) (Romano et al., 1997).
Polymorphonuclear cells are the main cellular components that
igrate to acute inﬂammatory sites induced by carrageenan.When
ice were pre-treated with EO, the number of total leukocytes
as markedly suppressed (25% of the control level). In addition,
O appeared to suppress the activation of leukocytes. This was
onﬁrmed by its inhibitory effect on NO production and on iNOS
xpression. The enzyme iNOS, which is expressed and activated
n diverse cell types by stimulation with TNF and/or LPS during
nﬂammation, produces high amounts of NO (Yui et al., 1991; Xie
t al., 1993; Eigler et al., 1997; Adams et al., 2002). NO is one of the
ost important mediators produced during the inﬂammatory pro-
ess, and it functions as an important regulatory molecule that can
nﬂuence numerous physiological functions, including vasodilata-
ion resulting in vascular leakage (Marletta et al., 1988; Moncada
t al., 1991). EO also inhibited PGE2, TNF, and IFN production. The
nhibitory effect on IFN production was more pronounced, com-
ared to that observed for NO, PGE2, and TNF levels. The increase
n TNF levels in the SAP were accompanied by a corresponding
ncrease in IFN.No signiﬁcant increase in the level of TNF, a cytokine
hat plays an important role in acute phase reactions and immune
esponse (Heinrich et al., 1990; Van Snick, 1990; Park et al., 2008),
as observed. In summary, our results suggest that EO selectively
ffects inﬂammatory cells.
In contrast to a previous study reported by Mendes et al. (2010),
he composition of the chemical used in this study contained a large
mount of carvacrol (44.43% vs. 7.53–5.31%) compared to the Lip-
ia gracilis used in the previous study. In contrast, the chemotype
romMendes showed thymol as themajor component, followed by
-cymene and methyl thymol. Although the structures of the com-
oundsmentionedabove are similar, small changes in the structure
ay elicit signiﬁcantly different biological responses.
The high content of carvacrol in the EO used in our study may
artially explain the observed anti-inﬂammatory and antinocicep-
ive activities. The antinociceptive activity of carvacrol has been
emonstrated in models of acetic acid-induced contortion and
ormalin-induced licking (Guimarães et al., 2010). Additionally, it
s known to regulate as well as the activation of PPAR- and - and
he suppression of COX2 enzyme (Katsukawa et al., 2010).
Although the complete mechanisms underlying the actions of
O remain tobeelucidated, it is clear that this compoundcan inhibit
nﬂammatory responses by blocking the NO pathway and can also
ttenuate hypernociception by blocking the opioid and cholinergic
ystems. Despite the fact that the mode of action of EO remains
nclear, our results strongly indicate that EO or EO-constituents
ould prove to be promising candidates for the direct or adjunct
elief of pain and inﬂammation.
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